Improving genomic research through advanced sequencing technologies
Official title: Epigenomics Core
Funded at Oklahoma Medical Research Foundation · NIH-11019320 · Data updated 2026-11-12
This study is working to improve how we understand genes and their functions by using advanced technology to look at how DNA works, which could eventually help in finding better treatments for genetic conditions that affect patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | June 10, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $319,387 |
| NIH project number | 1P20GM156711-01 |
| Project ID | NIH-11019320 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with genetic disorders or those involved in studies related to immunity and cellular function.
✕Less likely to help
Patients with conditions unrelated to genetic regulation or those not involved in relevant research areas may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing genomic regulation studies by upgrading sequencing capabilities at the Oklahoma Medical Research Foundation. It aims to provide advanced services such as chromatin accessibility analysis and DNA-binding protein localization, which are crucial for understanding genetic regulation. By employing experienced personnel and utilizing next-generation sequencing technologies, the project will support various research initiatives, including those related to immunity and cellular processes. Patients may benefit indirectly as the findings could lead to better understanding and treatment of genetic conditions.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding genetic regulation, potentially improving treatment options for various conditions.
How similar studies have gone: Other research has shown success with similar advanced sequencing approaches, indicating a promising potential for breakthroughs in genomic studies.
Where this research is happening
-
Oklahoma Medical Research Foundation
Oklahoma City, United States Active
Researchers
- Principal investigator: Wiley, Graham — Oklahoma Medical Research Foundation
- Study coordinator: Wiley, Graham
Related research
Other NIH-funded projects on the same topics.
-
Understanding how DIS3L2 helps keep RNA in check to help lupus patients
A physician-scientist team is studying how a watchdog molecule for RNA (DIS3L2) may drive lupus-related immune problems, with the goal of uncovering new paths to treatment.
-
Stem cell mRNA marks and fat-infiltrated aging muscles
Researchers are studying how aging changes muscle at the cellular level, including fat and fibrous tissue buildup, to help keep older adults stronger and more mobile.
-
Tissue research hub for autoimmune diseases to speed up new treatments
A national program is building a centralized tissue core to study autoimmune diseases like lupus, rheumatoid arthritis, Sjögren’s, and psoriatic conditions using advanced single-cell and spatial analysis.
-
Roles of mitochondrial transporters SLC25A22 and SLC25A46 in brain health
This grant studies how two mitochondrial transporters, SLC25A22 and SLC25A46, affect brain metabolism and neurological disorders using fruit-fly models to uncover disease mechanisms.
-
Colon mucus sugars and how they help keep gut bacteria and the colon healthy
Researchers are looking at how sugar-coated mucus made by cells in the front part of the colon helps keep gut bacteria balanced and may protect people with ulcerative colitis or pouch inflammation.
-
Oxidized lipids driving aging-related muscle loss
This project explores how certain lipid molecules that are damaged or modified over time contribute to muscle weakness and loss in older adults, with the goal of identifying new ways to prevent sarcopenia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.